Jonathan Lopez
Impact in
- Molecular Biology top 5%
- Cell death mechanisms and regulation
- Mitochondrial Function and Pathology
- Immunology top 5%
- interferon and immune responses
Papers in
-
- Thyroid Cancer Diagnosis and Treatment 15
- Oncology 16
- Cancer Immunotherapy and Biomarkers 7
- PARP inhibition in cancer therapy 3
- Co-authors
- Stephen W. G. Tait (8 shared papers)Andrew Oberst (4 shared papers)Joel S. Riley (4 shared papers)Françoise Descôtes (26 shared papers)Jim O’Prey (2 shared papers)Kevin M. Ryan (2 shared papers)Myriam Decaussin‐Petrucci (17 shared papers)Catherine Cloix (1 shared paper)
- Journals
- Nature Communications (7 papers)European Journal of Cancer (5 papers)British Journal of Cancer (3 papers)Modern Pathology (3 papers)Cancers (3 papers)
- Partner nations
- FranceUnited KingdomUnited States
In The Last Decade
Jonathan Lopez
100 papers receiving 3.5k citations
Jonathan Lopez's Hit Papers
Peers
Comparison fields: 5 of 100
- Molecular Biology 1.4k
- Immunology 378
- Oncology 395
- Cancer Research 231
- Endocrinology, Diabetes and Metabolism 253
Countries citing papers authored by Jonathan Lopez
This map shows the geographic impact of Jonathan Lopez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Lopez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Lopez more than expected).
Fields of papers citing papers by Jonathan Lopez
This network shows the impact of papers produced by Jonathan Lopez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Lopez. The network helps show where Jonathan Lopez may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonathan Lopez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 109 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mitochondrial apoptosis: killing cancer using the enemy within Hit paper breakdown → | 2015 | 646 |
| 2 | Mitochondrial inner membrane permeabilisation enables mtDNA release during apoptosis Hit paper breakdown → | 2018 | 462 |
| 3 | 2015 | 394 | |
| 4 | 2017 | 227 | |
| 5 | 2021 | 102 | |
| 6 | 2017 | 77 | |
| 7 | 2022 | 76 | |
| 8 | 2018 | 72 | |
| 9 | 2022 | 69 | |
| 10 | 2013 | 68 | |
| 11 | 2011 | 63 | |
| 12 | 2021 | 61 | |
| 13 | 2018 | 60 | |
| 14 | 2017 | 56 | |
| 15 | 2016 | 52 | |
| 16 | 2020 | 50 | |
| 17 | 2012 | 48 | |
| 18 | 2019 | 44 | |
| 19 | 2019 | 44 | |
| 20 | 2017 | 42 |
About Jonathan Lopez
Jonathan Lopez is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology, Molecular Biology, Reproductive Medicine and Surgery, having authored 109 papers that have together received 3.6k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (15 papers), Cell death mechanisms and regulation (15 papers), Cancer Immunotherapy and Biomarkers (7 papers), Salivary Gland Tumors Diagnosis and Treatment (7 papers), Ovarian cancer diagnosis and treatment (6 papers), TGF-β signaling in diseases (3 papers), PARP inhibition in cancer therapy (3 papers) and Gestational Trophoblastic Disease Studies (3 papers). The work is most often cited by research in Molecular Biology (1.4k citations), Immunology (378 citations), Oncology (395 citations), Cancer Research (231 citations) and Endocrinology, Diabetes and Metabolism (253 citations). Jonathan Lopez has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include Stephen W. G. Tait, Andrew Oberst, Joel S. Riley, Françoise Descôtes, Jim O’Prey, Kevin M. Ryan, Myriam Decaussin‐Petrucci, Catherine Cloix, Hiromi Sesaki and João F. Passos. Their work appears in journals such as Nature Communications, European Journal of Cancer, British Journal of Cancer, Modern Pathology and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.